Business Standard

Krebs Biochemicals & Industries reports standalone net loss of Rs 4.98 crore in the December 2023 quarter

Image

Sales rise 42.79% to Rs 12.98 crore

Net Loss of Krebs Biochemicals & Industries reported to Rs 4.98 crore in the quarter ended December 2023 as against net loss of Rs 5.55 crore during the previous quarter ended December 2022. Sales rose 42.79% to Rs 12.98 crore in the quarter ended December 2023 as against Rs 9.09 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales12.989.09 43 OPM %-16.10-32.78 -PBDT-3.25-3.86 16 PBT-4.98-5.55 10 NP-4.98-5.55 10

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 12 2024 | 2:26 PM IST

Explore News